Post Burn Cubital Tunnel Syndrome Response to High Intensity Laser Therapy Versus Shock Wave Therapy

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other, Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Significant morbidity in burn patients occurs frequently because of Post burn nerve entrapment syndromes. Nerve entrapment arises due to direct compression because of edema; they may also present due to scar tissue formation. Burns of the forearm and elbow are associated with swelling, redness and pain. In second to third-degree burns, the eschar forms a tight band constricting the circulation distally and forms edema that leads to compression neuropathy of ulnar nerve. Also the hyper metabolic response of the burned patients, has been suggested as a cause of the peripheral neuropathies, as the basal metabolic rate (B.M.R) of the burned patients increase more than 2 to 2.5 times normal.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 50
Healthy Volunteers: f
View:

• Age 20-50 years.

• Both sexes.

• Post healed elbow burn.

• Diagnosed with cubital tunnel syndrome.

• Willing and able to provide informed consent.

Locations
Other Locations
Egypt
Out patient clinic , faculty of Physical Therapy, Benha university
RECRUITING
Banhā
Out patient clinic , faculty of Physical Therapy, ahram Canadian university
RECRUITING
Giza
Contact Information
Primary
Mahmoud Mohamed, Ph.D
mahmoud.mohamed@fpt.bu.edu.eg
01111750888
Backup
Waleed Mansour, Ph.D
01005311168
Time Frame
Start Date: 2025-08-05
Estimated Completion Date: 2026-05-01
Participants
Target number of participants: 75
Treatments
Experimental: High intensity laser therapy
Device: High intensity laser therapy 25 Patients
Active_comparator: Shock Wave therapy
Extracorporeal shock wave therapy, 25 patients
Active_comparator: Ulnar nerve gliding exercises.
Ulnar nerve gliding exercises, 25 patients
Related Therapeutic Areas
Sponsors
Collaborators: Benha University
Leads: Ahram Canadian University

This content was sourced from clinicaltrials.gov